Genetics, Stress, and the Risk for Addiction

Stress and Addiction

Volumn , Issue , 2007, Pages 127-146

  Enoch, Mary Anne ^a  

^a NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 44649165909     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012370632-4/50009-7     Document Type: Chapter

References (163)

1. Adinoff B., Junghanns K., Kiefer F., Krishnan-Sarin S. Suppression of the HPA axis stress-response: Implications for relapse. Alcohol Clin Exp Res 2005, 29:1351-1355.
2. Diagnostic and statistical manual of mental disorders 1994, American Psychiatric Association, Author, Washington, DC. 4th ed.
3. Arias A., Feinn R., Kranzler H.R. Association of an Asn40Asp (A118G) polymorphism in the mu-opioid receptor gene with substance dependence: A meta-analysis. Drug Alcohol Depend 2006, 83:262-268. December 29.
4. Barna I., Zelena D., Arszovszki A.C., Ledent C. The role of endogenous cannabinoids in the hypothalamo-pituitary-adrenal axis regulation: In vivo and in vitro studies in CB1 receptor knockout mice. Life Sci 2004, 75:2959-2970.
5. Barr C.S., Newman T.K., Becker M.L., Champoux M., Lesch K.P., Suomi S.J., Goldman D., Higley J.D. Serotonin transporter gene variation is associated with alcohol sensitivity in rhesus macaques exposed to early-life stress. Alcohol Clin Exp Res 2003, 27:812-817.
6. Barr C.S., Newman T.K., Lindell S., Shannon C., Champoux M., Lesch K.P., Suomi S.J., Goldman D., Higley J.D. Interaction between serotonin transporter gene variation and rearing condition in alcohol preference and consumption in female primates. Arch Gen Psychiatry 2004, 61:1146-1152.
7. Barrot M., Olivier J.D., Perrotti L.I., DiLeone R.J., Berton O., Eisch A.J., Impey S., Storm D.R., Neve R.L., Yin J.C., Zachario V., Nestler E.J. CREB activity in the nucleus accumbens shell controls gating of behavioral responses to emotional stimuli. Proc Natl Acad Sci U S A 2002, 99:11430-11440.
8. Bart G., Kreek M.J., Ott J.F., LaForge K.S., Proudnikov D., Pollak L., Heilig M. Increased attributable risk related to a functional mu-opioid receptor gene polymorphism in association with alcohol dependence in central Sweden. Neuropsychopharmacology 2005, 30:417-422.
9. Bartels M., de Geus E.J., Kirschbaum C., Sluyter F. Heritability of daytime cortisol levels in children. Behav Genet 2003, 33:421-433.
10. Basavarajappa B.S., Hungund B.L. Role of the endocannabinoid system in the development of tolerance to alcohol. Alcohol Alcohol 2005, 40:15-24.
11. Belfer I., Hipp H., McKnight C., Evans C., Buzas B., Bollettino A., Albaugh B., Virkkunen M., Yuan Q., Max M.B., Goldman D., Enoch M.A. Association of galanin haplotypes with alcoholism and anxiety in two ethnically distinct populations. Mol Psychiatry 2006, 11:301-311.
12. Bergen A.W., Kokoszka J., Peterson R., Long J.C., Virkkunen M., Linnoila M., Goldman D. Mu opioid receptor gene variants: Lack of association with alcohol dependence. Mol Psychiatry 1997, 2:490-494.
13. Berrendero F., Kieffer B.L., Maldonado R. Attenuation of nicotine-induced antinociception, rewarding effects, and dependence in mu-opioid receptor knock-out mice. J Neurosci 2002, 22:10935-10940.
14. Bierut L.J., Dinwiddie S.H., Begleiter H., Crowe R.R., Hesselbrock V., Nurnberger J.I., Porjesz B., Schuckit M.A., Reich T. Familial transmission of substance dependence: Alcohol, marijuana, cocaine and habitual smoking. Arch Gen Psychiatry 1998, 55:982-988.
15. Bond C., LaForg K.S., Tian M., Melia D., Zhang S., Borg L., Gong J., Schluger J., Strong J.A., Leal S.M., Tischfield J.A., Kreek M.J., Yu L. Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: Possible implications for opiate addiction. Proc Natl Acad Sci U S A 1998, 95:9608-9613.
16. Bruijnzeel A.W., Gold M.S. The role of corticotropin-releasing factor-like peptides in cannabis, nicotine, and alcohol dependence. Brain Res Rev 2005, 49:505-528.
17. Carrier E.J., Patel S., Hillard C.J. Endocannabinoids in neuroimmunology and stress. Curr Drug Targets CNS Neurol Disord 2005, 4:657-665.
18. Caspi A., McClay J., Moffitt T.E., Mill J., Martin J., Craig I.W., Taylor A., Poulton R. Role of genotype in the cycle of violence in maltreated children. Science 2002, 297:851-853.
19. Caspi A., Moffitt T.E., Cannon M., McClay J., Murray R., Harrington H., Taylor A., Arseneault L., Williams B., Braithwaite A., Poulton R., Craig I.W. Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: Longitudinal evidence of a gene X environment interaction. Biol Psychiatry 2005, 57:1117-1127.
20. Caspi A., Sugden K., Moffitt T.E., Taylor A., Craig I.W., Harrington H., McClay J., Mill J., Martin J., Braithwaite A., Poulton R. Influence of life stress on depression: Moderation by a polymorphism in the 5-HTT gene. Science 2003, 301:386-389.
21. Charney D.S. Psychobiological mechanisms of resilience and vulnerability: Implications for successful adaptation to extreme stress. Am J Psychiatry 2004, 161:195-216.
22. Chen J., Lipska B.K., Halim N., Ma Q.D., Matsumoto M., Melhem S., Kolachana B.S., Hyde T.M., Herman M.M., Apud J., Egan M.F., Kleinman J.E., Weinberger D.R. Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): Effects on mRNA, protein, and enzyme activity in postmortem human brain. Am J Hum Genet 2004, 75:807-821.
23. Chong R.Y., Oswald L., Yang X., Uhart M., Lin P.I., Wand G.S. The mu-opioid receptor polymorphism A118G predicts cortisol responses to naloxone and stress. Neuropsychopharmacology 2006, 31:204-211.
24. Cohen C., Perrault G., Griebel G., Soubrie P. Nicotine-associated cues maintain nicotine-seeking behavior in rats several weeks after nicotine withdrawal: Reversal by the cannabinoid (CB1) receptor antagonist, rimonabant (SR141716). Neuropsychopharmacology 2005, 30:145-155.
25. Colilla S., Lerman C., Shields P.G., Jepson C., Rukstalis M., Berlin J., DeMichele A., Bunin G., Strom B.L., Rebbeck T.R. Association of catechol-O-methyltransferase with smoking cessation in two independent studies of women. Pharmacogenet Genomics 2005, 15:393-398.
26. Covault J., Gelernter J., Hesselbrock V., Nellissery M., Kranzler H.R. Allelic and haplotypic association of GABRA2 with alcohol dependence. Am J Med Genet (Neuropsychiatr Genet) 2004, 129B:104-109.
27. Covington H.E., Miczek K.A. Intense cocaine self-administration after episodic social defeat stress, but not after aggressive behavior: Dissociation from corticosterone activation. Psychopharmacology (Berl) 2005, 183:331-340.
28. Dai X., Thavundayil J., Gianoulakis C. Differences in the peripheral levels of beta-endorphin in response to alcohol and stress as a function of alcohol dependence and family history of alcoholism. Alcohol Clin Exp Res 2005, 29:1965-1975.
29. DeRijk R., de Kloet E.R. Corticosteroid receptor genetic polymorphisms and stress responsivity. Endocrine 2005, 28:263-270.
30. Di S., Malcher-Lopes R., Halmos K.C., Tasker J.G. Nongenomic glucocorticoid inhibition via endocannabinoid release in the hypothalamus: A fast feedback mechanism. J Neurosci 2003, 23:4850-4857.
31. Drevets W.C. Neuroimaging abnormalities in the amygdala in mood disorders. Ann N Y Acad Sci 2003, 985:420-444.
32. Edenberg H.J., Dick D.M., Xuei X., Tian H., Almasy L., Bauer L.O., Crowe R.R., Goate A., Hesselbrock V., Jones K., Kwon J., Li T.K., Nurnberger J.I., O'Connor S.J., Reich T., Rice J., Schuckit M.A., Porjesz B., Foroud T., Begleiter H. Variations in GABRA2, encoding the alpha 2 subunit of the GABA(A) receptor, are associated with alcohol dependence and with brain oscillations. Am J Hum Genet 2004, 74:705-714.
33. Enoch, M. A., Schwartz, L., Albaugh, B., Virkkunen, M., Goldman, D. (In press). Dimensional anxiety mediates linkage of GABRA2 haplotypes with alcoholism. AM J Med Genet Neuropsychiatr Genet.
34. Enoch M.A., Waheed J., Harris C.R., Albaugh B., Goldman D. Sex differences in the influence of COMT Val158Met on alcoholism and smoking in Plains American Indians. Alcohol Clin Exp Res 2006, 30:399-406.
35. Enoch M.A., Xu K., Ferro E., Harris C.R., Goldman D. Genetic origins of anxiety in women: A role for a functional catechol-O-methyltransferase polymorphism. Psychiatr Genet 2003, 13:33-41.
36. Federenko I.S., Nagamine M., Hellhammer D.H., Wadha P.D., Wust S. The heritability of hypothalamus pituitary adrenal axis responses to psychosocial stress is context dependent. J Clin Endocrinol Metab 2004, 89:6244-6250.
37. Feinn R., Nellissery M., Kranzler H.R. Meta-analysis of the association of a functional serotonin transporter promoter polymorphism with alcohol dependence. Am J Med Genet B Neuropsychiatr Genet 2005, 133:79-84.
38. Foley D.L., Eaves L.J., Wormley B., Silberg J.L., Maes H.H., Kuhn J., Riley B. Childhood adversity, monoamine oxidase a genotype, and risk for conduct disorder. Arch Gen Psychiatry 2004, 61:738-744.
39. Fromme K., de Wit H., Hutchison K.E., Ray L., Corbin W.R., Cook T.A., Wall T.L., Goldman D. Biological and behavioral markers of alcohol sensitivity. Alcohol Clin Exp Res 2004, 28:247-256.
40. Gianoulakis C. Influence of the endogenous opioid system on high alcohol consumption and genetic predisposition to alcoholism. J Psychiatry Neurosci 2001, 26:304-318.
41. Glatz K., Mossner R., Heils A., Lesch K.P. Glucocorticoid-regulated human serotonin transporter (5-HTT) expression is modulated by the 5-HTT gene-promoter-linked polymorphic region. J Neurochem 2003, 86:1072-1078.
42. Goldman D., Oroszi G., Ducci F. The genetics of addictions: Uncovering the genes. Nat Rev Genet 2005, 6:521-532.
43. Grant B.F., Hasin D.S., Chou S.P., Stinson F.S., Dawson D.A. Nicotine dependence and psychiatric disorders in the United States: Results from the national epidemiologic survey on alcohol and related conditions. Arch Gen Psychiatry 2004, 61:1107-1115.
44. Hahn M.K., Mazei-Robison M.S., Blakely R.D. Single nucleotide polymorphisms in the human norepinephrine transporter gene affect expression, trafficking, antidepressant interaction, and protein kinase C regulation. Mol Pharmacol 2005, 68:457-466.
45. Hallikainen T., Lachman H., Saito T., Volavka J., Kauhanen J., Salonen J.T., Ryynanen O., Koulu M., Karvonen M.K., Pohjalainen T., Syvalahti E., Hietala J., Tiihonen J. Lack of association between the functional variant of the catechol-o-methyltransferase (COMT) gene and early-onset alcoholism associated with severe antisocial behavior. Am J Med Genet 2000, 96:348-352.
46. Hariri A.R., Drabant E.M., Munoz K.E., Kolachana B.S., Mattay V.S., Egan M.F., Weinberger D.R. A susceptibility gene for affective disorders and the response of the human amygdala. Arch Gen Psychiatry 2005, 62:146-152.
47. Haughey H.M., Kaiser A.L., Johnson T.E., Bennett B., Sikela J.M., Zahniser N.R. Norepinephrine transporter: A candidate gene for initial ethanol sensitivity in inbred long-sleep and short-sleep mice. Alcohol Clin Exp Res 2005, 29:1759-1768.
48. Heilig M. The NPY system in stress, anxiety and depression. Neuropeptides 2004, 38:213-224.
49. Heilig M., Thorsell A. Brain neuropeptide Y (NPY) in stress and alcohol dependence. Rev Neurosci 2002, 13:85-94.
50. Heinz A., Braus D.F., Smolka M.N., Wrase J., Puls I., Hermann D., Klein S., Grusser S.M., Flor H., Schumann G., Mann K., Buchel C. Amygdala-prefrontal coupling depends on a genetic variation of the serotonin transporter. Nat Neurosci 2005, 8:20-21.
51. Heinz A., Jones D.W., Bissette G., Hommer D., Ragan P., Knable M., Wellek S., Linnoila M., Weinberger D.R. Relationship between cortisol and serotonin metabolites and transporters in alcoholism. Pharmacopsychiatry 2002, 35:127-134.
52. Heinz A., Jones D.W., Gorey J.G., Bennet A., Suomi S.J., Weinberger D.R., Higley J.D. Serotonin transporter availability correlates with alcohol intake in non-human primates. Mol Psychiatry 2003, 8:231-234.
53. Heinz A., Reimold M., Wrase J., Hermann D., Croissant B., Mundle G., Dohmen B.M., Braus D.F., Schumann G., Machulla H.J., Bares R., Mann K. Correlation of stable elevations in striatal μ-opioid receptor availability in detoxified alcoholic patients with alcohol craving: A positron emission tomography study using carbon 11-labeled carfentanil. Arch Gen Psychiatry 2005, 62:57-64.
54. Herman J.P., Mueller N.K., Figueiredo H. Role of GABA and glutamate circuitry in hypothalamo-pituitary-adrenocortical stress integration. Ann N Y Acad Sci 2004, 1018:35-45.
55. Hernandez-Avila C.A., Wand G., Luo X., Gelernter J., Kranzler H.R. Association between the cortisol response to opioid blockade and the Asn40Asp polymorphism at the mu-opioid receptor locus (OPRM1). Am J Med Genet B Neuropsychiatr Genet 2003, 118:60-65.
56. Hettema J.M., Corey L.A., Kendler K.S. A multivariate genetic analysis of the use of tobacco, alcohol and caffeine in a population-based sample of male and female twins. Drug Alcohol Depend 1999, 57:69-78.
57. Hicks B.M., Krueger R.F., Iacono W.G., McGue M., Patrick C.J. Family transmission and heritability of externalizing disorders: A twin-family study. Arch Gen Psychiatry 2004, 61:922-928.
58. Higley J.D., Hasert M.F., Suomi S.J., Linnoila M. Nonhuman primate model of alcohol abuse: Effects of early experience, personality, and stress on alcohol consumption. Proc Natl Acad Sci U S A 1991, 88:7261-7265.
59. Horowitz R., Kotler M., Shufman E., Aharoni S., Kremer I., Cohen H., Ebstein R.P. Confirmation of an excess of the high enzyme activity COMT val allele in heroin addicts in a family-based haplotype relative risk study. Am J Med Genet 2000, 96:599-603.
60. Hsu F.C., Zhang G.J., Raol Y.S., Valentino R.J., Coulter D.A., Brooks-Kayal A.R. Repeated neonatal handling with maternal separation permanently alters hippocampal GABAA receptors and behavioral stress responses. Proc Natl Acad Sci U S A 2003, 100:12213-12218.
61. Hu X., Oroszi G., Chun J., Smith T.L., Goldman D., Schuckit M.A. An expanded evaluation of the relationship of four alleles to the level of response to alcohol and the alcoholism risk. Alcohol Clin Exp Res 2005, 29:8-16.
62. Hu X.Z., Lipsky R.H., Zhu G., Akhtar L.A., Taubman J., Greenberg B.D., Xu K., Arnold P.D., Richter M.A., Kennedy J.L., Murphy D.L., Goldman D. Serotonin transporter promoter gain-of-function genotypes are linked to obsessive-compulsive disorder. Am J Hum Genet 2006, 78:815-826.
63. Hungund B.L., Szakall I., Adam A., Basavarajappa B.S., Vadasz C. Cannabinoid CB1 receptor knockout mice exhibit markedly reduced voluntary alcohol consumption and lack alcohol-induced dopamine release in the nucleus accumbens. J Neurochem 2003, 84:698-704.
64. Huotari M., Gogos J.A., Karayiorgou M., Koponen O., Forsberg M., Raasmaja A., Hyttinen J., Mannisto P.T. Brain catecholamine metabolism in catechol-O-methyltransferase (COMT)-deficient mice. Eur J Neurosci 2002, 15:246-256.
65. Aa6 Pro385Ser substitution and benzodiazepine sensitivity. Am J Psychiatry 1999, 156:1447-1449.
66. Kauhanen J., Hallikainen T., Tuomainen T.P., Koulu M., Karvonen M.K., Salonen J.T., Tiihonen J. Association between the functional polymorphism of catechol-O-methyltransferase gene and alcohol consumption among social drinkers. Alcohol Clin Exp Res 2000, 24:135-139.
67. Kauhanen J., Karvonen M.K., Pesonen U., Koulu M., Tuomainen T.P., Uusitupa M.I., Salonen J.T. Neuropeptide Y polymorphism and alcohol consumption in middle-aged men. Am J Med Genet 2000, 93:117-121.
68. Kathuria S., Gaetani S., Fegley D., Valino F., Duranti A., Tontini A., Mor M., Tarzia G., La Rana G., Calignano A., Giustino A., Tattoli M., Palmery M., Cuomo V., Piomelli D. Modulation of anxiety through blockade of anandamide hydrolysis. Nat Med 2003, 9:76-81.
69. Kendler K.S., Davis C.G., Kessler R.C. The familial aggregation of common psychiatric and substance abuse disorders in the National Comorbidity Survey: A family history study. Br J Psychiatry 1997, 170:541-548.
70. Kendler K.S., Jacobson K.C., Prescott C.A., Neale M.C. Specificity of genetic and environmental risk factors for use and abuse/dependence of cannabis, cocaine, hallucinogens, sedatives, stimulants, and opiates in male twins. Am J Psychiatry 2003, 160:687-695.
71. Kendler K.S., Karkowski L.M., Neale M.C., Prescott C.A. Illicit psychoactive use, heavy use, abuse, and dependence in a US population-based sample of male twins. Arch Gen Psychiatry 2000, 57:261-269.
72. Kendler K.S., Kuhn J.W., Vittum J., Prescott C.A., Riley B. The interaction of stressful life events and a serotonin transporter polymorphism in the prediction of episodes of major depression: A replication. Arch Gen Psychiatry 2005, 62:529-535.
73. Kendler K.S., Prescott C.A., Myers J., Neale M.C. The structure of genetic and environmental risk factors for common psychiatric and substance use disorders in men and women. Arch Gen Psychiatry 2003, 60:929-937.
74. Khoshbouei H., Cecchi M., Dove S., Javors M., Morilak D.A. Behavioral reactivity to stress: Amplification of stress-induced noradrenergic activation elicits a galanin-mediated anxiolytic effect in central amygdala. Pharmacol Biochem Behav 2002, 71:407-417.
75. Knopik V.S., Heath A.C., Madden P.A., Bucholz K.K., Slutske W.S., Nelson E.C., Statham D., Whitfield J.B., Martin N.G. Genetic effects on alcohol dependence risk: Re-evaluating the importance of psychiatric and other heritable risk factors. Psychol Med 2004, 34:1519-1530.
76. Koob G.F. Alcoholism: Allostasis and beyond. Alcohol Clin Exp Res 2003, 27:232-243.
77. Kreek M.J., Bart G., Lilly C., Laforge K.S., Nielsen D.A. Pharmacogenetics and human molecular genetics of opiate and cocaine addictions and their treatments. Pharmacol Rev 2005, 57:1-26.
78. Kruger R.F. The structure of common mental disorders. Arch Gen Psychiatry 1999, 56:921-926.
79. Lappalainen J., Kranzler H.R., Malison R., Price L.H., Van Dyck C., Rosenheck R.A., Cramer J., Southwick S., Charney D., Krystal J., Gelernter J. A functional neuropeptide Y Leu7Pro polymorphism associated with alcohol dependence in a large population sample from the United States. Arch Gen Psychiatry 2002, 59:825-831.
80. Laviolette S.R., Gallegos R.A., Henriksen S.J., van der Kooy D. Opiate state controls bidirectional reward signaling via GABAA receptors in the ventral tegmental area. Nat Neurosci 2004, 7:160-169.
81. Laviolette S.R., Nader K., van der Kooy D. Motivational state determines the functional role of the mesolimbic dopamine system in the mediation of opiate reward processes. Behav Brain Res 2002, 129:17-29.
82. Le A.D., Harding S., Juzytsch W., Funk D., Shaham Y. Role of alpha-2 adrenoceptors in stress-induced reinstatement of alcohol seeking and alcohol self-administration in rats. Psychopharmacology (Berl) 2005, 179:366-373.
83. Le A.D., Harding S., Juzytsch W., Watchus J., Shalev U., Shaham Y. The role of corticotropin-releasing factor in stress-induced relapse to alcohol-seeking behavior in rats. Psychopharmacology (Berl) 2000, 150:317-324.
84. Lee S., Smith G.W., Vale W., Lee K.F., Rivier C. Mice that lack corticotropin-releasing factor (CRF) receptors type 1 show a blunted ACTH response to acute alcohol despite up-regulated constitutive hypothalamic CRF gene expression. Alcohol Clin Exp Res 2001, 25:427-433.
85. Lerman C., Wileyto E.P., Patterson F., Rukstalis M., Audrain-McGovern J., Restine S., Shields P.G., Kaufmann V., Redden D., Benowitz N., Berrettini W.H. The functional mu opioid receptor (OPRM1) Asn40Asp variant predicts short-term response to nicotine replacement therapy in a clinical trial. Pharmacogenomics J 2004, 4:184-192.
86. Lesch K.P., Bengel D., Heils A., Sabol S.Z., Greenberg B.D., Petri S., Benjamin J., Muller C.R., Hamer D.H., Murphy D.L. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 1996, 274:1527-1531.
87. Li T., Chen C.K., Hu X., Ball D., Lin S.K., Chen W., Sham P.C., Loh el-W., Murray R.M., Collier D.A. Association analysis of the DRD4 and COMT genes in methamphetamine abuse. Am J Med Genet B Neuropsychiatr Genet 2004, 129B:120-124.
88. Linnoila M., Virkkunen M., George T., Eckardt M., Higley J.D., Nielsen D., Goldman D. Serotonin, violent behavior and alcohol. EXS 1994, 71:155-163.
89. Liu D., Diorio J., Tannenbaum B., Caldji C., Francis D., Freedman A., Sharma S., Pearson D., Plotsky P.M., Meaney M.J. Maternal care, hippocampal glucocorticoid receptors, and hypothalamic-pituitary-adrenal responses to stress. Science 1997, 277:1659-1662.
90. Lodge D.J., Lawrence A.J. The CRF1 receptor antagonist antalarmin reduces volitional ethanol consumption in isolation-reared fawn-hooded rats. Neuroscience 2003, 117:243-247.
91. Lovallo W.R. Cortisol secretion patterns in addiction and addiction risk. Int J Psychophysiol 2006, 59:195-202.
92. Low K., Crestani F., Keist R., Benke D., Brunig I., Benson J.A., Fritschy J.M., Rulicke T., Bluethmann H., Mohler H., Rudolph U. Molecular and neuronal substrate for the selective attenuation of anxiety. Science 2000, 290:131-134.
93. Mannelli P., Patkar A.A., Murray H.W., Certa K., Peindl K., Mattila-Evenden M., Berrettini W.H. Polymorphism in the serotonin transporter gene and response to treatment in African American cocaine and alcohol-abusing individuals. Addict Biol 2005, 10:261-268.
94. Manzanares J., Ortiz S., Oliva J.M., Perez-Rial S., Palomo T. Interactions between cannabinoid and opioid receptor systems in the mediation of ethanol effects. Alcohol Alcohol 2005, 40:25-34.
95. Martijena I.D., Rodriguez Manzanares P.A., Lacerra C., Molina V.A. Gabaergic modulation of the stress response in frontal cortex and amygdala. Synapse 2002, 45:86-94.
96. Mazzanti C.M., Lappalainen J., Long J.C., Bengel D., Naukkarinen H., Eggert M., Virkkunen M., Linnoila M., Goldman D. Role of the serotonin transporter promoter polymorphism in anxiety-related traits. Arch Gen Psychiatry 1998, 55:936-940.
97. Meaney M.J. Maternal care, gene expression, and the transmission of individual differences in stress reactivity across generations. Annu Rev Neurosci 2001, 24:1161-1192.
98. Merikangas K.R., Mehta R.L., Molnar B.E., Walters E.E., Swendsen J.D., Aguilar-Gaziola S., Bijl R., Borges G., Caraveo-Anduaga J.J., DeWit D.J., Kolody B., Vega W.A., Wittchen H.U., Kessler R.C. Comorbidity of substance use disorders with mood and anxiety disorders: Results of the International Consortium in Psychiatric Epidemiology. Addict Behav 1998, 23:893-907.
99. Merikangas K.R., Stolar M., Stevens D.E., Goulet J., Preisig M.A., Fenton B., Zhang H., O'Malley S.S., Rounsaville B.J. Familial transmission of substance use disorders. Arch Gen Psychiatry 1998, 55:973-979.
100. Miller G.M., Bendor J., Tiefenbacher S., Yang H., Novak M.A., Madras B.K. A mu-opioid receptor single nucleotide polymorphism in rhesus monkey: Association with stress response and aggression. Mol Psychiatry 2004, 9:99-108.
101. Morgan C.A., Rasmusson A.M., Wang S., Hoyt G., Hauger R.L., Hazlett G. Neuropeptide-Y, cortisol, and subjective distress in humans exposed to acute stress: Replication and extension of previous report. Biol Psychiatry 2002, 52:136-142.
102. Mottagui-Tabar S., Prince J.A., Wahlestedt C., Zhu G., Goldman D., Heilig M. A novel single nucleotide polymorphism of the neuropeptide Y (NPY) gene associated with alcohol dependence. Alcohol Clin Exp Res 2005, 29:702-707.
103. Nader K., van der Kooy D. Deprivation state switches the neurobiological substrates mediating opiate reward in the ventral tegmental area. J Neurosci 1997, 17:383-390.
104. Nagy J. The NR2B subtype of NMDA receptor: A potential target for the treatment of alcohol dependence. Curr Drug Targets CNS Neurol Disord 2004, 3:169-179.
105. NIDA (National Institute on Drug Abuse) Capsules, women and drug abuse 1994, 6:2.
106. Nie Z., Schweitzer P., Roberts A.J., Madamba S.G., Moore S.D., Siggins G.R. Ethanol augments GABAergic transmission in the central amygdala via CRF1 receptors. Science 2004, 303:1512-1514.
107. Nikulina E.M., Miczek K.A., Hammer R.P. Prolonged effects of repeated social defeat stress on mRNA expression and function of mu-opioid receptors in the ventral tegmental area of rats. Neuropsychopharmacology 2005, 30:1096-1103.
108. O'Connor T., Ben-Shlomo Y., Heron J., Golding J., Adams D., Glover V. Prenatal anxiety predicts individual differences in cortisol in pre-adolescent children. Biol Psychiatry 2005, 58:211-217.
109. Olsson C.A., Anney R.J., Lotfi-Miri M., Byrnes G.B., Williamson R., Patton G.C. Association between the COMT Val158Met polymorphism and propensity to anxiety in an Australian population-based longitudinal study of adolescent health. Psychiatr Genet 2005, 15:109-115.
110. O'Malley S.S., Krishnan-Sarin S., Farren C., Sinha R., Kreek M.J. Naltrexone decreases craving and alcohol self-administration in alcohol-dependent subjects and activates the hypothalamo-pituitary-adrenocortical axis. Psychopharmacology (Berl) 2002, 160:19-29.
111. Oslin D.W., Berrettini W., Kranzler H.R., Pettinati H., Gelernter J., Volpicelli J.R., O'Brien C.P. A functional polymorphism of the mu-opioid receptor gene is associated with naltrexone response in alcohol-dependent patients. Neuropsychopharmacology 2003, 28:1546-1552.
112. Oswald L.M., McCaul M., Choi L., Yang X., Wand G.S. Catechol-O-methyltransferase polymorphism alters hypothalamic-pituitary-adrenal axis responses to naloxone: A preliminary report. Biol Psychiatry 2004, 55:102-105.
113. Oswald L.M., Wand G.S. Opioids and alcoholism. Physiol Behav 2004, 81:339-358.
114. Oswald L.M., Zandi P., Nestadt G., Potash J.B., Kalaydjian A.E., Wand G.S. Relationship between cortisol responses to stress and personality. Neuropsychopharmacology 2006, 31:1583-1591. 11.
115. Pagotto U., Marsicano G., Cota D., Lutz B., Pasquali R. The emerging role of the endocannabinoid system in endocrine regulation and energy balance. Endocr Rev 2006, 27:73-100.
116. Pandey S.C., Carr L.G., Heilig M., Ilveskoski E., Thiele T.E. Neuropeptide Y and alcoholism: Genetic, molecular, and pharmacological evidence. Alcohol Clin Exp Res 2003, 27:149-154.
117. Pandey S.C., Chartoff E.H., Carlezon W.A., Zou J., Zhang H., Kreibich A.S., Blendy J.A., Crews F.T. CREB gene transcription factors: Role in molecular mechanisms of alcohol and drug addiction. Alcohol Clin Exp Res 2005, 29:176-184.
118. Pandey S.C., Zhang H., Roy A., Xu T. Deficits in amygdaloid cAMP-responsive element-binding protein signaling play a role in genetic predisposition to anxiety and alcoholism. J Clin Invest 2005, 115:2762-2773.
119. Patel S., Cravatt B.F., Hillard C.J. Synergistic interactions between cannabinoids and environmental stress in the activation of the central amygdala. Neuropsychopharmacology 2005, 30:497-507.
120. Patel S., Roelke C.T., Rademacher D.J., Cullinan W.E., Hillard C.J. Endocannabinoid signaling negatively modulates stress-induced activation of the hypothalamic-pituitary-adrenal axis. Endocrinology 2004, 145:5431-5438.
121. Pezawas L., Meyer-Lindenberg A., Drabant E.M., Verchinski B.A., Munoz K.E., Kolachana B.S., Egan M.F., Mattay V.S., Hariri A.R., Weinberger D.R. 5-HTTLPR polymorphism impacts human cingulate-amygdala interactions: A genetic susceptibility mechanism for depression. Nat Neurosci 2005, 8:828-834.
122. Racz I., Bilkei-Gorzo A., Toth Z.E., Michel K., Palkovits M., Zimmer A. A critical role for the cannabinoid CB1 receptors in alcohol dependence and stress-stimulated ethanol drinking. J Neurosci 2003, 23:2453-2458.
123. Radel M., Vallejo R.L., Iwata N., Aragon R., Long J.C., Virkkunen M., Goldman D. Haplotype-based localization of an alcohol dependence gene to the 5q34 {gamma}aminobutyric acid type A gene cluster. Arch Gen Psychiatry 2005, 62:47-55.
124. Ray L.A., Hutchison K.E. A polymorphism of the mu-opioid receptor gene (OPRM1) and sensitivity to the effects of alcohol in humans. Alcohol Clin Exp Res 2004, 28:1789-1795.
125. Rhee S.H., Hewitt J.K., Young S.E., Corley R.P., Crowley T.J., Stallings M.C. Genetic and environmental influences on substance initiation, use, and problem use in adolescents. Arch Gen Psychiatry 2003, 60:1256-1264.
126. Roberts A.J., McDonald J.S., Heyser C.J., Kieffer B.L., Matthes H.W., Koob G.F., Gold L.H. Mu-opioid receptor knockout mice do not self-administer alcohol. J Pharmacol Exp Ther 2000, 293:1002-1008.
127. Rodriguez de Fonseca F., Carrera M.R., Navarro M., Koob G.F., Weiss F. Activation of corticotropin-releasing factor in the limbic system during cannabinoid withdrawal. Science 1997, 276:2050-2054.
128. Schinka J.A., Town T., Abdullah L., Crawford F.C., Ordorica P.I., Francis E., Hughes P., Graves A.B., Mortimer J.A., Mullan M. A functional polymorphism within the mu-opioid receptor gene and risk for abuse of alcohol and other substances. Mol Psychiatry 2002, 7:224-228.
129. Sillaber I., Rammes G., Zimmermann S., Mahal B., Zieglgansberger W., Wurst W., Holsboer F., Spanagel R. Enhanced and delayed stress-induced alcohol drinking in mice lacking functional CRH1 receptors. Science 2002, 296:931-933.
130. Smolka M., Sander T., Schmidt L.G., Samochowiec J., Rommelspacher H., Gscheidel N., Wendel B., Hoche M.R. Mu-opioid receptor variants and dopaminergic sensitivity in alcohol withdrawal. Psychoneuroendocrinology 1999, 24:629-638.
131. Smolka M.N., Schumann G., Wrase J., Grusser S.M., Flor H., Mann K., Braus D.F., Goldman D., Buchel C., Heinz A. Catechol-O-methyltransferase val158met genotype affects processing of emotional stimuli in the amygdala and prefrontal cortex. J Neurosci 2005, 25:836-842.
132. Snoek H., Van Goozen S.H., Matthys W., Buitelaar J.K., van Engeland H. Stress responsivity in children with externalizing behavior disorders. Dev Psychopathol 2004, 16:389-406.
133. Soyka M., Preuss U.W., Koller G., Zill P., Hesselbrock V., Bondy B. No association of CRH1 receptor polymorphism haplotypes, harm avoidance and other personality dimensions in alcohol dependence: Results from the Munich gene bank project for alcoholism. Addict Biol 2004, 9:73-79.
134. Stewart S.H., Karp J., Pih R.O., Peterson R.A. Anxiety sensitivity and self-reported reasons for drug use. J Subst Abuse 1997, 9:223-240.
135. Stinson F.S., Grant B.F., Dawson D.A., Ruan W.J., Huang B., Saha T. Comorbidity between DSM-IV alcohol and specific drug use disorders in the United States: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Drug Alcohol Depend 2005, 80:105-116.
136. Swan G.E., Carmelli D., Cardon L.R. Heavy consumption of cigarettes, alcohol and coffee in male twins. J Stud Alcohol 1997, 58:182-190.
137. Thomas S.E., Randall C.L., Carrigan M.H. Drinking to cope in socially anxious individuals: A controlled study. Alcohol Clin Exp Res 2003, 27:1937-1943.
138. Thorsell A., Rimondini R., Heilig M. Blockade of central neuropeptide Y (NPY) Y2 receptors reduces ethanol self-administration in rats. Neurosci Lett 2002, 332:1-4.
139. Tiihonen J., Hallikainen T., Lachman H., Saito T., Volavka J., Kauhanen J., Salonen J.T., Ryynanen O.P., Koulu M., Karvonen M.K., Pohjalainen T., Syvalahti E., Hietala J. Association between the functional variant of the catechol-O-methyltransferase (COMT) gene and type 1 alcoholism. Mol Psychiatry 1999, 4:286-289.
140. Treutlein J., Kissling C., Frank J., Wiemann S., Dong L., Depner M., Saam C., Lascorz J., Soyka M., Preuss U.W., Rujescu D., Skowronek M.H., Rietschel M., Spaangel R., Heinz A., Laucht M., Mann K., Schumann G. Genetic association of the human corticotropin releasing hormone receptor 1 (CRHR1) with binge drinking and alcohol intake patterns in two independent samples. Mol Psychiatry 2006, 11:594-602.
141. True W.R., Heath A.C., Scherrer J.F., Xian H., Lin N., Eisen S.A., Lyons M.J., Goldberg J., Tsuang M.T. Interrelationship of genetic and environmental influences on conduct disorder and alcohol and marijuana dependence symptoms. Am J Med Genet 1999, 88:391-397.
142. True W.R., Xian H., Scherrer J.F., Madden P.A., Bucholz K.K., Heath A.C., Eisen S.A., Lyons M.J., Goldberg J., Tsuang M. Common genetic vulnerability for nicotine and alcohol dependence in men. Arch Gen Psychiatry 1999, 56:655-661.
143. Tsai G., Coyle J.T. The role of glutamatergic neurotransmission in the pathophysiology of alcoholism. Annu Rev Med 1998, 49:173-184.
144. Tsuang M.T., Bar J.L., Harley R.M., Lyons M.J. The Harvard twin study of substance abuse: What we have learned. Harvard Rev Psychiatry 2001, 9:267-279.
145. Tsuang M.T., Lyons M.J., Meyer J.M., Doyle T., Eisen S.A., Goldberg J., True W., Lin N., Toomey R., Eaves L. Co-occurrence of abuse of different drugs in men: The role of drug-specific and shared vulnerabilities. Arch Gen Psychiatry 1998, 55:967-972.
146. Vandenbergh D.J., Rodriguez L.A., Miller I.T., Uhl G.R., Lachman H.M. High-activity catechol-O-methyltransferase allele is more prevalent in polysubstance abusers. Am J Med Genet 1997, 74:439-442.
147. Ventura R., Alcaro A., Puglisi-Allegra S. Prefrontal cortical norepinephrine release is critical for morphine-induced reward, reinstatement and dopamine release in the nucleus accumbens. Cereb Cortex 2005, 15:1877-1886.
148. Walters C.L., Cleck J.N., Kuo Y.-C., Blendy J.A. Mu-opioid receptor and CREB activation are required for nicotine reward. Neuron 2005, 46:933-943.
149. Wand G. The anxious amygdala: CREB signaling and predisposition to anxiety and alcoholism. J Clin Invest 2005, 115:2697-2699.
150. Wand G.S., McCaul M., Yang X., Reynolds J., Gotjen D., Lee S., Ali A. The mu-opioid receptor gene polymorphism (A118G) alters HPA axis activation induced by opioid receptor blockade. Neuropsychopharmacology 2002, 26:106-114.
151. Wang J., Fang Q., Liu Z., Lu L. Regionspecific effects of brain corticotropin-releasing factor receptor type 1 blockade on footshock-stress- or drug-priming-induced reinstatement of morphine conditioned place preference in rats. Psychopharmacology (Berl) 2006, 185:19-28.
152. Weaver I.C., Cervoni N., Champagne F.A., D'Alessio A.C., Sharma S., Seckl J.R., Dymov S., Szyf M., Meaney M.J. Epigenetic programming by maternal behavior. Nat Neurosci 2004, 7:847-854.
153. Weaver I.C., Champagne F.A., Brown S.E., Dymov S., Sharma S., Meaney M.J., Szyf M. Reversal of maternal programming of stress responses in adult offspring through methyl supplementation: Altering epigenetic marking later in life. J Neurosci 2005, 25:11045-11054.
154. Weinshilboum R.M., Otterness D.M., Szumlanski C.L. Methylation pharmacogenetics: Catechol-O-methyltransferase, thiopurine methyl transferase, and histamine N-methyltransferase. Annu Rev Pharmacol Toxicol 1999, 39:19-52.
155. Wilsnack S.C., Vogeltanz N.D., Klassen A.D., Harris T.R. Childhood sexual abuse and women's substance abuse: National survey findings. J Stud Alcohol 1997, 58:264-271.
156. Winfield I., George L.K., Swartz M., Blazer D.G. Sexual assault and psychiatric disorders among a community sample of women. Am J Psychiatry 1990, 147:335-341.
157. Wust S., Federenko I., Hellhammer D.H., Kirschbaum C. Genetic factors, perceived chronic stress, and the free cortisol response to awakening. Psychoneuroendocrinology 2000, 25:707-720.
158. Wust S., van Rossum E.F., Federenko I.S., Koper J.W., Kumsta R., Hellhammer D.H. Common polymorphisms in the glucocorticoid receptor gene are associated with adrenocortical responses to psychosocial stress. J Clin Endocrinol Metab 2004, 89:565-573.
159. Yoshitake T., Wang F.H., Kuteeva E., Holmberg K., Yamaguchi M., Crawley J.N., Steiner R., Bartfai T., Ogren S.O., Hokfelt T., Kehr J. Enhanced hippocampal noradrenaline and serotonin release in galanin-overexpressing mice after repeated forced swimming test. Proc Natl Acad Sci U S A 2004, 101:354-359.
160. Young E.A., Abelson J.A., Cameron O.G. Interaction of brain noradrenergic system and the hypothalamic-pituitary-adrenal (HPA) axis in man. Psychoneuroendocrinology 2005, 30:807-814.
161. Zhang P.W., Ishiguro H., Ohtsuki T., Hess J., Carillo F., Walther D., Onaivi E.S., Arinami T., Uhl G.R. Human cannabinoid receptor 1:5′ exons, candidate regulatory regions, polymorphisms, haplotypes and association with polysubstance abuse. Mol Psychiatry 2004, 9:916-931.
162. Zhu G., Pollak L., Mottagui-Tabar S., Wahlestedt C., Taubman J., Virkkunen M., Goldman D., Heilig M. NPY leu7pro and alcohol dependence in Finnish and Swedish populations. Alcohol Clin Exp Res 2003, 27:19-24.
163. Zubieta J.K., Heitzeg M.M., Smith Y.R., Bueller J.A., Xu K., Xu Y., Koeppe R.A., Stohler C.S., Goldman D. COMT val158met genotype affects mu-opioid neurotransmitter responses to a pain stressor. Science 2003, 299:1240-1243.